Lung cancer is a prevalent disease that kills one million people worldwide each year. The MSLN Stable Cell Line - CHO-K1 was utilized by researchers to investigate CAR-T treatment in non-small cell lung cancer (NSCLC) and mesothelioma. These second-generation CAR-T cells, which target mesothelin (MSLN), included co-stimulatory CD28 and 4-1BB signaling domains to increase proliferation. Flow cytometry validated the successful production of CAR-T cells, and cytotoxicity tests using the LDH kit proved the ability to kill target cells. In vivo investigations on a mouse model inoculated with tumor-derived cells from patients revealed that CAR-T MSLN cells dramatically inhibited tumor growth when injected into the tail vein, underscoring the potential and problems of CAR-T therapy in solid tumors.
Figure 1. The researchers utilized the MSLN Stable Cell Line - CHO-K1 to study MSLN expression, as evidenced by flow cytometry and LDH cytotoxicity assays. (Ye L, et al., 2019)
Customer Reviews
High stability
Compared to traditional transient transfection or virus transduction assay kits, this product exhibits higher gene expression stability in cell lines after use. The experimental data shows that there is no significant fluctuation in the expression level of the MSLN gene, and the experimental results are reliable.
United Kingdom
08/11/2020
Write a Review